Developmental regression as a red flag

Define time course. Hyperacute loss suggests stroke, seizure, trauma, toxin, infection or acute metabolic disturbance. Subacute progression over weeks can reflect inflammation, tumour, epileptic encephalopathy or evolving neuromuscular disease. Months-to-years regression raises neurodegenerative, metabolic and genetic disorders. Stepwise or episodic loss suggests seizures, relapsing inflammation or metabolic decompensation; apparent fluctuation can also reflect fatigue.

Map the first and subsequent domains affected. Motor loss may localise to brain, spinal cord, peripheral nerve, neuromuscular junction or muscle. Language loss can occur with autism, hearing loss, epilepsy and neurodegeneration. Social withdrawal can reflect pain, anxiety, depression or adverse experience. Loss of continence or self-care can be neurological, behavioural or environmental and needs the same careful chronology.

History includes pregnancy and birth, previous development, seizures or subtle spells, headache, vision, hearing, swallowing, weakness, movement disorder, sleep, behaviour and cognition. Ask about fever, travel, fasting, diet, medications and access to toxins; developmental and neurodegenerative disease in relatives; consanguinity and unexplained childhood deaths. Review school reports and ask whether academic skills have been lost rather than only grades falling.

Examine during and between episodes if possible. Plot growth and head circumference; assess skin and dysmorphism, vision and hearing, organomegaly, cardiac and respiratory status. Neurological examination covers consciousness, cranial nerves, tone, power, reflexes, coordination, gait and movement. Look for Gowers manoeuvre, calf hypertrophy and respiratory weakness in a boy with motor loss.

Seizure-related regression can occur through frequent clinical seizures, infantile spasms or sleep-activated epileptiform activity that disrupts cognition and language. Infantile spasms may be brief symmetric flexion or extension clusters around waking and mistaken for colic or startle. Loss of visual engagement or social responsiveness can be the presenting deterioration. NICE requires urgent tertiary assessment because rapid treatment affects outcome.

Neurodegenerative and neurometabolic diseases are individually rare but collectively important. Clues include progressive loss, abnormal movements, ataxia, neuropathy, vision or hearing decline, organomegaly, coarse features, unusual odour and worsening with fasting or infection. Some disorders are treatable, so involve metabolic or neurology specialists early and obtain samples during decompensation when advised.

Neuromuscular regression often presents as reduced running, stairs, rising from the floor or endurance rather than loss of all walking. Ask about falls, calf pain, swallowing, morning headache and recurrent chest infection. NICE advises CK consideration in boys with motor regression to help identify Duchenne muscular dystrophy before specialist review. Markedly raised CK requires urgent interpretation, counselling and genetic pathway referral, not strenuous repeat testing.

Autistic regression most often involves language or social communication in early childhood, but autism is not the only explanation and does not account for motor loss or encephalopathy. NICE routes children under 3 with language or social regression to an autism team. After age 3, language regression and any-age motor regression require paediatrician or paediatric neurologist assessment before or alongside autism assessment.

Apparent regression has important mimics. Conductive or sensorineural hearing loss can make words disappear from use; visual loss reduces play; pain and arthritis reduce mobility; severe sleep disorder suppresses skills; depression or trauma can cause withdrawal; school change may expose previously compensated difficulty. Investigate these without dismissing caregiver observation. A functional presentation is diagnosed positively after appropriate neurological assessment, not because initial tests are normal.

First-line acute investigation is driven by ABCDE and differential: bedside glucose, blood gas, electrolytes, calcium, liver function, FBC and inflammatory tests as indicated, toxicology when exposure is possible and infection testing when appropriate. Save blood or urine for metabolic testing after specialist discussion. Lumbar puncture is contraindicated until raised intracranial pressure and instability are assessed.

Neurological investigation is stepwise. EEG is indicated for suspected seizures or epileptic encephalopathy; a sleep recording may be essential and a negative routine study does not exclude epilepsy. MRI brain and sometimes spine is selected for focal signs, head-growth change, motor regression or suspected structural or degenerative disease. Ophthalmology, audiology, neurophysiology, CK, genomic and metabolic tests follow the phenotype.

Management treats time-critical causes and protects skills. Control seizures using syndrome-specific guidance, correct metabolic decompensation with a specialist emergency regimen and support breathing or swallowing in neuromuscular disease. Continue physiotherapy without exhausting weak muscle, provide augmentative communication, adapt education and support nutrition. Explain uncertainty honestly and provide a named contact because progressive investigations are distressing for families.

Safeguarding runs in parallel. Consider inflicted head injury, poisoning, fabricated or induced illness, neglect and severe psychosocial adversity when the history, examination or access pattern raises concern. Do not assume regression is environmental because a family is stressed, and do not ignore home safety because a rare disease is suspected. Record the child's and caregiver's words and share concerns through the local pathway.